Literature DB >> 27016557

Urinary Tract Infections: Resistance Is Futile.

Eric Wenzler1, Larry H Danziger2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27016557      PMCID： PMC4808218          DOI： 10.1128/AAC.00006-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  17 in total

1.  Has antifungal susceptibility testing come of age?

Authors:  John H Rex; Michael A Pfaller
Journal:  Clin Infect Dis       Date:  2002-09-24       Impact factor: 9.079

2.  Antibiotics in the critically ill: the bug, drug, host triad.

Authors:  Andrew F Shorr
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

3.  In vitro assessment of urinary isolates of ampicillin-resistant enterococci.

Authors:  John C Williamson; David W Craft; John D Butts; Ralph H Raasch
Journal:  Ann Pharmacother       Date:  2002-02       Impact factor: 3.154

Review 4.  Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap!

Authors:  Paul G Ambrose; Sujata M Bhavnani; Evelyn J Ellis-Grosse; George L Drusano
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

5.  Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis.

Authors:  Seung Soon Lee; Youngsu Kim; Doo Ryeon Chung
Journal:  J Infect       Date:  2010-11-03       Impact factor: 6.072

Review 6.  The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens.

Authors:  Y-H Chen; W-C Ko; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

7.  Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections.

Authors:  T A Stamey; W R Fair; M M Timothy; M A Millar; G Mihara; Y C Lowery
Journal:  N Engl J Med       Date:  1974-11-28       Impact factor: 91.245

8.  Absence of bioactive metabolites of ampicillin and amoxycillin in man.

Authors:  M Cole; B Ridley
Journal:  J Antimicrob Chemother       Date:  1978-11       Impact factor: 5.790

9.  Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections.

Authors:  Ya-Sung Yang; Chih-Hung Ku; Jung-Chung Lin; Shih-Ta Shang; Chun-Hsiang Chiu; Kuo-Ming Yeh; Chu-Chun Lin; Feng-Yee Chang
Journal:  J Microbiol Immunol Infect       Date:  2010-06       Impact factor: 4.399

10.  Outcomes of Aminopenicillin Therapy for Vancomycin-Resistant Enterococcal Urinary Tract Infections.

Authors:  Kelli A Cole; Rachel M Kenney; Mary Beth Perri; Lisa E Dumkow; Linoj P Samuel; Marcus J Zervos; Susan L Davis
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191
View more
  1 in total

1.  Reply to "Urinary Tract Infections: Resistance Is Futile".

Authors:  Rachel M Kenney; Kelli A Cole; Mary Beth Perri; Lisa E Dumkow; Linoj P Samuel; Marcus J Zervos; Susan L Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.